Clinical Trial Update: Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for D2C7-IT in combination with 2141-V11 in recurrent malignant glioma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• 2141-V11
• D2C7-IT

Snippet

Sponsor: Darell Bigner | Conditions: Glioma, Malignant | Phase 1 | Status: RECRUITING